We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+11.7%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$334B
AUM Growth
+$44B
Cap. Flow
+$10.5B
Cap. Flow %
3.13%
Top 10 Hldgs %
13.87%
Holding
10,649
New
1,223
Increased
4,779
Reduced
2,816
Closed
1,397

Sector Composition

Rank Sector Weight
1 Technology 13.13%
2 Financials 7.1%
3 Healthcare 6%
4 Consumer Discretionary 5.02%
5 Industrials 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPT
5376
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$353K ﹤0.01%
27,527
-51,239
-65% -$583K
FORR icon
5377
Forrester Research
FORR
$224M
$351K ﹤0.01%
13,105
-51,994
-80% -$1.35M
GRNT icon
5378
Granite Ridge Resources
GRNT
$644M
$351K ﹤0.01%
58,338
+40,709
+231% +$249K
LABU icon
5379
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$631M
$351K ﹤0.01%
+2,878
New +$220K
ABUS icon
5380
Arbutus Biopharma
ABUS
$915M
$350K ﹤0.01%
139,971
+77,353
+124% +$151K
CLMB icon
5381
Climb Global Solutions
CLMB
$519M
$350K ﹤0.01%
25,524
+10,568
+71% +$126K
FBIZ icon
5382
First Business Financial Services
FBIZ
$595M
$350K ﹤0.01%
8,722
+4,383
+101% +$147K
CFFI icon
5383
C&F Financial
CFFI
$286M
$350K ﹤0.01%
5,129
+3,326
+184% +$194K
TXG icon
5384
10x Genomics
TXG
$6.61B
$349K ﹤0.01%
6,229
-4,882
-44% -$212K
RSPR icon
5385
Invesco S&P 500 Equal Weight Real Estate ETF
RSPR
$99.9M
$348K ﹤0.01%
10,475
-1,531
-13% -$45.6K
IAE
5386
Voya Asia Pacific High Dividend Equity Income Fund
IAE
$93.1M
$348K ﹤0.01%
57,875
-4,753
-8% -$27.1K
TBCH
5387
Turtle Beach Corp
TBCH
$277M
$348K ﹤0.01%
31,762
+20,292
+177% +$199K
ANIK icon
5388
Anika Therapeutics
ANIK
$287M
$348K ﹤0.01%
15,346
+5,970
+64% +$124K
PPC icon
5389
Pilgrim's Pride
PPC
$6.54B
$348K ﹤0.01%
12,566
-846
-6% -$21.5K
RAYC
5390
DELISTED
Rayliant Quantamental China Equity ETF
RAYC
$348K ﹤0.01%
27,151
-5,290
-16% -$72K
PD icon
5391
PUT
PagerDuty
PD
$902M
$347K ﹤0.01%
15,000
-1,400
-9% -$30.3K
EBTC
5392
DELISTED
Enterprise Bancorp
EBTC
$347K ﹤0.01%
10,753
+5,226
+95% +$147K
DMO
5393
Western Asset Mortgage Opportunity Fund
DMO
$120M
$346K ﹤0.01%
30,942
+4,637
+18% +$49.6K
TBT icon
5394
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$305M
$345K ﹤0.01%
11,419
+4,867
+74% +$183K
WIA
5395
Western Asset Inflation-Linked Income Fund
WIA
$186M
$344K ﹤0.01%
42,425
-3,305
-7% -$26.1K
NXDT
5396
NexPoint Diversified Real Estate Trust
NXDT
$238M
$344K ﹤0.01%
43,262
+23,996
+125% +$196K
BSRR icon
5397
Sierra Bancorp
BSRR
$525M
$344K ﹤0.01%
15,246
+7,121
+88% +$138K
IRMD icon
5398
iRadimed
IRMD
$1.18B
$344K ﹤0.01%
7,238
+4,349
+151% +$183K
PBPB
5399
DELISTED
Potbelly
PBPB
$342K ﹤0.01%
32,863
+18,996
+137% +$173K
HIE
5400
DELISTED
Miller/Howard High Income Equity Fund
HIE
$342K ﹤0.01%
32,257
+177
+0.6% +$1.78K

Similar funds

UBS Group's Q4 2023 Portfolio in Review

As of Q4 2023, UBS Group held 10,649 positions worth $334B, up 15% from $290B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $10.5B of net new capital in Q4 2023, opening 1,223 new positions and adding to 4,779 existing holdings. Its largest new stake was Veralto: 498,566 shares worth $41M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $503M trimmed.

  • UBS Group's largest Q4 2023 buy was Veralto: 498,566 shares worth $41M.
  • UBS Group added most to UBS Group in Q4 2023, an estimated $591M increase.
  • UBS Group's biggest Q4 2023 reduction was Invesco QQQ Trust, cutting an estimated $503M.
  • UBS Group fully exited Activision Blizzard in Q4 2023, selling an estimated $370M.
  • UBS Group's ten largest holdings make up 14% of its $334B portfolio in Q4 2023.
  • UBS Group opened 1,223 new positions and closed 1,397 in Q4 2023.
  • UBS Group's portfolio value rose 15% quarter-over-quarter to $334B.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.